Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
400 participants
OBSERVATIONAL
2023-01-01
2023-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Each patient will have 12 lead ECG prior, and daily during radiotherapy.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Atrial Fibrillation and Other Cardiac Arrhythmias and Diseases After Radiotherapy for Breast Cancer : Watch Your HeaRT
NCT06073509
Stereotactic Radioablation for the Treatment of Refractory Atrial Fibrillation
NCT04833712
Stereotactic Management of Arrhythmia - Radiosurgery Treatment and Evaluation of Response in Ventricular Tachycardia
NCT05913375
Cut-off Values of 6-min Walk Test and Sit-to-stand Test for Determining Symptom Burden and Functional Impairment in Atrial Fibrillation
NCT04754360
Radiotherapy and Atrial Fibrillation
NCT04575662
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Inclusing Criteria:
1. Patients with radiotherapy for thoracic malignancy or breast cancer
2. Between 18-99 years-old
Exclusion Criteria:
1. Patients with history of radiotherapy
2. Patients with history of atrial fibrillation
3. Patients with pacemaker implantation
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with Thoracic Malignancies
All patients undergoing RT for Thoracic Malignancies
ECG
12 lead ecg for each participant
Patients with Breast Cancer
All patients undergoing RT for Breast Cancer
ECG
12 lead ecg for each participant
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ECG
12 lead ecg for each participant
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Between 18-99 years-old
Exclusion Criteria
* Patients with history of atrial fibrillation
* Patients with pacemaker implantation
18 Years
99 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Istanbul University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Cafer Zorkun
Head, Division of CardioOncology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Cafer Zorkun, MD PhD
Role: PRINCIPAL_INVESTIGATOR
Faculty member
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Istanbul Faculty of Medicine
Fatih, Istanbul, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
COEXIST-1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.